Literature DB >> 8445012

The roles of insulin and catecholamines in the glucoregulatory response during intense exercise and early recovery in insulin-dependent diabetic and control subjects.

C Purdon1, M Brousson, S L Nyveen, P D Miles, J B Halter, M Vranic, E B Marliss.   

Abstract

Intense exercise is associated with a marked stimulation of glucose production (Ra), a somewhat smaller increment in its utilization (Rd) (and therefore hyperglycemia), large increases in plasma catecholamines, and moderate hyperglucagonemia. The hyperglycemia increases in recovery and is accompanied by hyperinsulinemia. Because these adaptations are unique to intense exercise, we tested the physiological significance of the hyperinsulinemia by exercising six fit, postabsorptive young male subjects with insulin-dependent diabetes mellitus (IDDM) after overnight glycemic normalization by iv insulin, keeping its infusion rate constant during and for 2 h after 100% maximum VO2 cycle ergometer exercise to exhaustion (12 min) (no postexercise hyperinsulinemia). Their responses were compared with those of matched control subjects studied on two separate occasions, once without intervention (physiological hyperinsulinemia, n = 6) and again with a 0.05 U/kg iv bolus at exhaustion (postexercise supraphysiological hyperinsulinemia, n = 5). In all three study protocols, Ra increased by 7-fold, and Rd by 4-fold at exhaustion, and Ra declined in early recovery at the same rates. Therefore, the early recovery hyperinsulinemia is not required to return Ra to preexercise levels, and excessive hyperinsulinemia does not accelerate this decline. We infer that the catecholamine increments and decrements are the prime regulators of Ra (correlations of Ra vs. norepinephrine or epinephrine, P < 0.001 in the three studies), with a smaller contribution from the concurrent hyperglucagonemia. Rd, in contrast, was significantly affected by insulin. In the IDDM subjects, Rd remained at the same rate as Ra through most of recovery, resulting in sustained hyperglycemia and decreased glucose MCR, vs. the control subjects. This hyperglycemia compensated for the abnormal MCR, such that Rd was comparable to that in the control subjects. With the insulin bolus, the Rd elevation was sustained longer compared to the study without bolus, resulting in mild hypoglycemia successfully counterregulated by an increase in Ra. Thus, the principal regulators of the marked exercise increase and rapid recovery decrease in Ra are probably the catecholamines. The postexercise hyperinsulinemia is required for the MCR response and to return plasma glucose concentrations to preexercise levels. Different therapeutic strategies are required in persons with IDDM undergoing strenuous vs. moderate exercise, because of their inability to generate the postexercise hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445012     DOI: 10.1210/jcem.76.3.8445012

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Antecedent hypoglycaemia does not diminish the glycaemia-increasing effect and glucoregulatory responses of a 10 s sprint in people with type 1 diabetes.

Authors:  Raymond J Davey; Nirubasini Paramalingam; Adam J Retterath; Ee Mun Lim; Elizabeth A Davis; Timothy W Jones; Paul A Fournier
Journal:  Diabetologia       Date:  2014-03-16       Impact factor: 10.122

Review 2.  Artificial Pancreas Systems and Physical Activity in Patients with Type 1 Diabetes: Challenges, Adopted Approaches, and Future Perspectives.

Authors:  Sémah Tagougui; Nadine Taleb; Joséphine Molvau; Élisabeth Nguyen; Marie Raffray; Rémi Rabasa-Lhoret
Journal:  J Diabetes Sci Technol       Date:  2019-08-13

Review 3.  Exercise and the Development of the Artificial Pancreas: One of the More Difficult Series of Hurdles.

Authors:  Michael C Riddell; Dessi P Zaharieva; Loren Yavelberg; Ali Cinar; Veronica K Jamnik
Journal:  J Diabetes Sci Technol       Date:  2015-10-01

Review 4.  New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus: implications for existing guidelines.

Authors:  Kym J Guelfi; Timothy W Jones; Paul A Fournier
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

5.  Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study.

Authors:  K Chokkalingam; K Tsintzas; J E M Snaar; L Norton; B Solanky; E Leverton; P Morris; P Mansell; I A Macdonald
Journal:  Diabetologia       Date:  2007-07-18       Impact factor: 10.122

6.  Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study.

Authors:  Karen M Rothacker; Sam Armstrong; Grant J Smith; Nat Benjanuvatra; Brendan Lay; Peter Adolfsson; Timothy W Jones; Paul A Fournier; Elizabeth A Davis
Journal:  Diabetologia       Date:  2021-05-04       Impact factor: 10.122

7.  Effects of performing resistance exercise before versus after aerobic exercise on glycemia in type 1 diabetes.

Authors:  Jane E Yardley; Glen P Kenny; Bruce A Perkins; Michael C Riddell; Janine Malcolm; Pierre Boulay; Farah Khandwala; Ronald J Sigal
Journal:  Diabetes Care       Date:  2012-02-28       Impact factor: 19.112

Review 8.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

9.  Metabolic and hormonal responses to a single session of kumite (free non-contact fight) and kata (highly ritualized fight) in karate athletes.

Authors:  S Benedini; S Longo; A Caumo; L Luzi; P L Invernizzi
Journal:  Sport Sci Health       Date:  2012-11-17

10.  Resistance versus aerobic exercise: acute effects on glycemia in type 1 diabetes.

Authors:  Jane E Yardley; Glen P Kenny; Bruce A Perkins; Michael C Riddell; Nadia Balaa; Janine Malcolm; Pierre Boulay; Farah Khandwala; Ronald J Sigal
Journal:  Diabetes Care       Date:  2012-11-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.